134 related articles for article (PubMed ID: 10222351)
1. Combined inhibin and CA125 assays in the detection of ovarian cancer.
Robertson DM; Cahir N; Burger HG; Mamers P; McCloud PI; Pettersson K; McGuckin M
Clin Chem; 1999 May; 45(5):651-8. PubMed ID: 10222351
[TBL] [Abstract][Full Text] [Related]
2. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
[TBL] [Abstract][Full Text] [Related]
3. Inhibin forms in serum from postmenopausal women with ovarian cancers.
Robertson DM; Cahir N; Burger HG; Mamers P; Groome N
Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065
[TBL] [Abstract][Full Text] [Related]
4. Total inhibin is a potential serum marker for epithelial ovarian cancer.
Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
[TBL] [Abstract][Full Text] [Related]
5. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours.
Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N
Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307
[TBL] [Abstract][Full Text] [Related]
6. Inhibins/activins as diagnostic markers for ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; Burger HG; McCloud P; Tsigos A; Groome N; Mamers P; McNeilage J; Jobling T; Healy D
Mol Cell Endocrinol; 2002 May; 191(1):97-103. PubMed ID: 12044923
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
[TBL] [Abstract][Full Text] [Related]
8. Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors.
Ala-Fossi SL; Mäenpää J; Bläuer M; Tuohimaa P; Punnonen R
Eur J Endocrinol; 2000 Apr; 142(4):334-9. PubMed ID: 10754473
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
[TBL] [Abstract][Full Text] [Related]
10. Inhibins and ovarian cancer.
Robertson DM; Pruysers E; Burger HG; Jobling T; McNeilage J; Healy D
Mol Cell Endocrinol; 2004 Oct; 225(1-2):65-71. PubMed ID: 15451569
[TBL] [Abstract][Full Text] [Related]
11. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
Haltia UM; Hallamaa M; Tapper J; Hynninen J; Alfthan H; Kalra B; Ritvos O; Heikinheimo M; Unkila-Kallio L; Perheentupa A; Färkkilä A
Gynecol Oncol; 2017 Jan; 144(1):83-89. PubMed ID: 27871721
[TBL] [Abstract][Full Text] [Related]
12. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer.
Lambert-Messerlian GM; Steinhoff M; Zheng W; Canick JA; Gajewski WH; Seifer DB; Schneyer AL
Gynecol Oncol; 1997 Jun; 65(3):512-6. PubMed ID: 9190984
[TBL] [Abstract][Full Text] [Related]
13. [Inhibin and ovarian cancer].
Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
Vopr Onkol; 1999; 45(4):369-73. PubMed ID: 10532093
[TBL] [Abstract][Full Text] [Related]
14. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma.
Menon U; Riley SC; Thomas J; Bose C; Dawnay A; Evans LW; Groome NP; Jacobs IJ
BJOG; 2000 Sep; 107(9):1069-74. PubMed ID: 11002947
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of inhibin in granulosa cell tumors of the ovary.
Jobling T; Mamers P; Healy DL; MacLachlan V; Burger HG; Quinn M; Rome R; Day AJ
Gynecol Oncol; 1994 Nov; 55(2):285-9. PubMed ID: 7959297
[TBL] [Abstract][Full Text] [Related]
17. Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol.
Rey RA; Lhommé C; Marcillac I; Lahlou N; Duvillard P; Josso N; Bidart JM
Am J Obstet Gynecol; 1996 Mar; 174(3):958-65. PubMed ID: 8633676
[TBL] [Abstract][Full Text] [Related]
18. Detection of high circulating concentrations of inhibin pro- and -alphaC immunoreactivity in mares with granulosa-theca cell tumours.
Watson ED; Heald M; Leask R; Groome NP; Riley SC
Equine Vet J; 2002 Mar; 34(2):203-6. PubMed ID: 11902764
[No Abstract] [Full Text] [Related]
19. The inhibins and ovarian cancer.
Burger HG; Fuller PJ; Chu S; Mamers P; Drummond A; Susil B; Neva P; Robertson DM
Mol Cell Endocrinol; 2001 Jun; 180(1-2):145-8. PubMed ID: 11451584
[TBL] [Abstract][Full Text] [Related]
20. Inhibin as a marker for ovarian cancer.
Cooke I; O'Brien M; Charnock FM; Groome N; Ganesan TS
Br J Cancer; 1995 May; 71(5):1046-50. PubMed ID: 7734297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
